Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren E Mays

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cell Research|October 10, 2007
Maintaining immunological tolerance with Foxp3Lauren E Mays, Youhai H Chen
The Journal of Gene Medicine|September 25, 2009
Identification of the murine AAVrh32.33 capsid-specific CD8+ T cell epitopesLauren E Mays, James M Wilson
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 2, 2010
The complex and evolving story of T cell activation to AAV vector-encoded transgene productsLauren E Mays, James M Wilson
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 20, 2013
AAV8 induces tolerance in murine muscle as a result of poor APC transduction, T cell exhaustion, and minimal MHCI upregulation on target cellsLauren E Mays, Lili Wang, Jianping Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteinsLauren E Mays, Luk H Vandenberghe, Ru Xiao, et al.
Journal of Structural Biology|April 8, 2014
The structure of AAVrh32.33, a novel gene delivery vectorKyle Mikals, Hyun-Joo Nam, Kim Van Vliet, et al.
Journal of Virology|May 31, 2013
Mapping the structural determinants responsible for enhanced T cell activation to the immunogenic adeno-associated virus capsid from isolate rhesus 32.33Lauren E Mays, Lili Wang, Rebeca Tenney, et al.
The European Respiratory Journal|November 18, 2011
CXCR1 and CXCR2 haplotypes synergistically modulate cystic fibrosis lung diseaseMichael S D Kormann, Andreas Hector, Veronica Marcos, et al.
Nature Biotechnology|January 11, 2011
Expression of therapeutic proteins after delivery of chemically modified mRNA in miceMichael S D Kormann, Günther Hasenpusch, Manish K Aneja, et al.
The Journal of Clinical Investigation|February 9, 2013
Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanismLauren E Mays, Susanne Ammon-Treiber, Benedikt Mothes, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cell Research|October 10, 2007
Maintaining immunological tolerance with Foxp3Lauren E Mays, Youhai H Chen
The Journal of Gene Medicine|September 25, 2009
Identification of the murine AAVrh32.33 capsid-specific CD8+ T cell epitopesLauren E Mays, James M Wilson
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 2, 2010
The complex and evolving story of T cell activation to AAV vector-encoded transgene productsLauren E Mays, James M Wilson
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 20, 2013
AAV8 induces tolerance in murine muscle as a result of poor APC transduction, T cell exhaustion, and minimal MHCI upregulation on target cellsLauren E Mays, Lili Wang, Jianping Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteinsLauren E Mays, Luk H Vandenberghe, Ru Xiao, et al.
Journal of Structural Biology|April 8, 2014
The structure of AAVrh32.33, a novel gene delivery vectorKyle Mikals, Hyun-Joo Nam, Kim Van Vliet, et al.
Journal of Virology|May 31, 2013
Mapping the structural determinants responsible for enhanced T cell activation to the immunogenic adeno-associated virus capsid from isolate rhesus 32.33Lauren E Mays, Lili Wang, Rebeca Tenney, et al.
The European Respiratory Journal|November 18, 2011
CXCR1 and CXCR2 haplotypes synergistically modulate cystic fibrosis lung diseaseMichael S D Kormann, Andreas Hector, Veronica Marcos, et al.
Nature Biotechnology|January 11, 2011
Expression of therapeutic proteins after delivery of chemically modified mRNA in miceMichael S D Kormann, Günther Hasenpusch, Manish K Aneja, et al.
The Journal of Clinical Investigation|February 9, 2013
Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanismLauren E Mays, Susanne Ammon-Treiber, Benedikt Mothes, et al.
Pageof 2